≥30 kg / m 2
≥27 to < 30 kg / m 2 +
NOW AVAILABLE FOR CHRONIC WEIGHT MANAGEMENT 1
DID YOU KNOW?
2 in 3
* Data from the Australian Bureau of Statistics National Health Survey 2022. 2
Australian adults are living with overweight or obesity 2 *
Available to prescribe for Chronic Weight Management 1 †
in adults with an initial body mass index( BMI) of:
≥30 kg / m 2
OR
≥27 to < 30 kg / m 2 +
≥1 weight-related comorbid condition 1 ‡
† As an adjunct to a reduced-calorie diet and increased physical activity. Chronic Weight Management includes weight loss and weight maintenance. 1
‡ For example, hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, prediabetes or type 2 diabetes mellitus. 1
Hypothetical patient.
Mounjaro is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management, including weight loss and weight maintenance, in adults with an initial body mass index( BMI) of ≥30 kg / m 2( obesity) or ≥27 kg / m 2 to < 30 kg / m 2( overweight) in the presence of at least one weight-related comorbid condition( e. g., hypertension, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, prediabetes or type 2 diabetes mellitus). 1
BMI = body mass index; CWM = Chronic Weight Management; GIP = glucose-dependent insulinotropic polypeptide; GLP-1 = glucagon-like peptide-1; HDL = high-density lipoprotein; LDL = low-density lipoprotein; LS = least squares; mITT = modified intent-to-treat; MMRM = mixed model for repeated measures; MTD = maximum tolerated dose.
References: 1. MOUNJARO ® Approved Product Information. 2. Australian Institute of Health and Welfare. Overweight and Obesity. Available at: https:// www. aihw. gov. au / reports / overweight-obesity / overweight-and-obesity / contents / overweight-and-obesity Accessed October 2024. 3. Willard FS, et al. JCI Insight 2020; 5( 17): e140532. 4. Aronne LJ, et al. JAMA 2024; 331( 1): 38 – 48( including supplement). 5. Jastreboff AM, et al. N Engl J Med 2022; 387( 3): 205 – 16( including supplement).